Stephen Baxter

Q: What is Stephen Baxter's success rate?

Stephen Baxter currently has a success rate of 94.45040270865952.

Q: What is the average return of Stephen Baxter's calls?

Their stock ratings have generated an average return of 32.451830941133956.

Wells Fargo | Healthcare

Stephen Baxter is an analyst from Wells Fargo specializing in the Healthcare sector. Ranked #711 out of 4721 analysts, they have issued 88 stock ratings with a success rate of 94.45% and an average return of 32.45%.

Stephen Baxter has a well-established track record, with 88 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 94.45% and an average return of 32.45%, underscoring their expertise and ability to identify winning opportunities for investors.

#711

Out of 4721

Total Ratings

+94.45%

Success Rate

+32.45%

Average Return

Recent Ratings Analysis

HUM

Buy

Jul 13, 2026

Target

$502.00

Current

$406.00

Performance

0.00%

Stephen Baxter rated HUM as Overweight on Jul 13, 2026, setting a price target of 502. Shares have remained stable near 406, leaving the 502 target still in play.

CNC

Hold

Jul 13, 2026

Target

$69.00

Current

$68.29

Performance

0.00%

On Jul 13, 2026, CNC was given a Equal-Weight rating by Stephen Baxter, with a target price of 69. Market indecision, reflected in sideways trading near 68.29, supported the cautious call.

CVS

Buy

Jul 13, 2026

Target

$123.00

Current

$105.90

Performance

0.00%

CVS received a Overweight rating from Stephen Baxter on Jul 13, 2026, aiming for 123. Price action was muted, as shares hovered around 105.9 despite the bullish outlook.

ELV

Buy

Jul 13, 2026

Target

$492.00

Current

$425.17

Performance

0.00%

On Jul 13, 2026, Stephen Baxter published a Overweight outlook on ELV, with a target of 492. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 425.17.

HCA

Hold

Jul 13, 2026

Target

$428.00

Current

$390.74

Performance

0.00%

Stephen Baxter on Jul 13, 2026 assigned HCA a Equal-Weight rating, with a price target of 428. The Hold stance reflected consolidation, as shares held near 390.74.

MOH

Hold

Jul 13, 2026

Target

$235.00

Current

$242.88

Performance

0.00%

On Jul 13, 2026, Stephen Baxter reaffirmed MOH with a Equal-Weight rating, targeting 235. The neutral call matched muted market action of 0.00%.

PNTG

Buy

Jul 13, 2026

Target

$45.00

Current

$39.86

Performance

0.00%

PNTG was rated Overweight by Stephen Baxter on Jul 13, 2026, with a price objective of 45. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

THC

Buy

Jul 13, 2026

Target

$231.00

Current

$194.81

Performance

0.00%

On Jul 13, 2026, Stephen Baxter initiated coverage on THC with a Overweight rating and target of 231. Neutral price movement of 0.00% leaves room for interpretation.

UHS

Hold

Jul 13, 2026

Target

$166.00

Current

$152.77

Performance

0.00%

Stephen Baxter issued a Equal-Weight recommendation for UHS on Jul 13, 2026, price target set at 166. The rating was appropriate for a consolidating market trading near 152.77.

UNH

Buy

Jul 13, 2026

Target

$485.00

Current

$429.09

Performance

0.00%

On Jul 13, 2026, UNH was evaluated by Stephen Baxter, who gave a Overweight rating and target of 485. So far, the Buy call awaits clearer momentum, with shares flat at 429.09.

AGL

Buy

Jul 13, 2026

Target

$141.00

Current

$115.85

Performance

0.00%

Stephen Baxter rated AGL as Overweight on Jul 13, 2026, setting a price target of 141. Shares have remained stable near 115.85, leaving the 141 target still in play.

BTSG

Buy

Jul 13, 2026

Target

$78.00

Current

$69.64

Performance

0.00%

On Jul 13, 2026, BTSG was given a Overweight rating by Stephen Baxter, with a target price of 78. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.

MCK

Hold

May 12, 2026

Target

$812.00

Current

$812.28

Performance

10.56%

MCK received a Equal-Weight rating from Stephen Baxter on May 12, 2026, aiming for 812. Investors saw gains of 10.56% that the cautious stance didn’t fully capture.

COR

Buy

May 11, 2026

Target

$331.00

Current

$306.13

Performance

17.88%

On May 11, 2026, Stephen Baxter published a Overweight outlook on COR, with a target of 331. Shares gained 17.88%, underscoring the accuracy of the bullish outlook toward 331.

CAH

Buy

May 01, 2026

Target

$245.00

Current

$233.66

Performance

—

Stephen Baxter on May 01, 2026 assigned CAH a Overweight rating, with a price target of 245. The recommendation remains pending validation as shares consolidate around 233.66.

CI

Hold

May 01, 2026

Target

$305.00

Current

$304.50

Performance

—

On May 01, 2026, Stephen Baxter reaffirmed CI with a Equal-Weight rating, targeting 305. The neutral call matched muted market action of %.

CON

Buy

Mar 05, 2026

Target

$28.00

Current

$31.39

Performance

—

CON was rated Overweight by Stephen Baxter on Mar 05, 2026, with a price objective of 28. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

MDLN

Hold

Feb 27, 2026

Target

$47.00

Current

$40.58

Performance

-14.59%

On Feb 27, 2026, Stephen Baxter initiated coverage on MDLN with a Equal-Weight rating and target of 47. The rating matched the stock’s inability to hold above 40.58.

CYH

Sell

Jan 07, 2026

Target

$3.00

Current

$3.48

Performance

6.75%

Stephen Baxter issued a Underweight recommendation for CYH on Jan 07, 2026, price target set at 3. The bearish outlook played out, as shares fell from 3.48 to 3.48.

OSCR

Sell

Nov 13, 2025

Target

$11.00

Current

$31.60

Performance

126.52%

On Nov 13, 2025, OSCR was evaluated by Stephen Baxter, who gave a Underweight rating and target of 11. Investors benefited from heeding the Sell stance, avoiding a 126.52% decline.

TDOC

Hold

Apr 29, 2024

Target

$15.00

Current

$9.65

Performance

-27.93%

Stephen Baxter rated TDOC as Equal-Weight on Apr 29, 2024, setting a price target of 15. The cautious Hold call aligned with subsequent weakness, as shares slipped 27.93%.

Frequency Asked Questions

Who is Stephen Baxter?

Stephen Baxter is an analyst from Wells Fargo specializing in the Healthcare sector.

What is Stephen Baxter's success rate?

Stephen Baxter currently has a success rate of +94.45%.

How many ratings has Stephen Baxter issued?

Stephen Baxter has issued 88 stock ratings so far.

What is the average return of Stephen Baxter's calls?

Their stock ratings have generated an average return of +32.45%.

What is Stephen Baxter's ranking?

Stephen Baxter is ranked #711 out of 4721 analysts.

What types of ratings does Stephen Baxter give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Stephen Baxter?

You can follow Stephen Baxter by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Stephen Baxter?

Their latest rating was a Buy on HUM issued on 2026-07-13.